drugset / Trial / NCT01603485

Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects

NCT01603485

Phase 1 Completed 16 enrolled Pfizer ViiV Healthcare · collab
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to estimate the pharmacokinetics (PK) of 3 different modified-release formulations of lersivirine and compare it to the PK of the immediate-release tablet. The effect of food on the PK of one of the modified-release tablets will also be assess along with the safety and tolerability of each treatment.

Timeline

Start
2012-06
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lersivirine Small molecule 500 mg

Indications

No indication recorded.